187
Views
1
CrossRef citations to date
0
Altmetric
Case reports

Efficacy of Gefapixant, a P2X3 Antagonist, for Refractory Atopic Cough

, ORCID Icon, , , , ORCID Icon, , & ORCID Icon show all
Pages 497-501 | Received 22 Jun 2023, Accepted 24 Aug 2023, Published online: 04 Sep 2023

References

  • Morice AH, Millqvist E, Bieksiene K, et al. ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J. 2020;55(1):1901136. PMID: 31515408. doi:10.1183/13993003.01136-2019
  • Mukae H, Kaneko T, Obase Y, et al. The Japanese respiratory society guidelines for the management of cough and sputum (digest edition). Respir Investig. 2021;59(3):270–290. PMID: 33642231. doi:10.1016/j.resinv.2021.01.007
  • Fujimura M, Niimi A, Naito K, et al. Guidelines for Diagnosis and Treatment of Prolonged and Chronic Cough for Cough Specialists. Kanazawa: Japan Cough Society. Maeda Syoten; 2021:27–31. In Japanese.
  • Fujimura M, Ogawa H, Yasui M, Matsuda T. Eosinophilic tracheobronchitis and airway cough hypersensitivity in chronic non-productive cough. Clin Exp Allergy. 2000;30(1):41–47. PMID: 10606929. doi:10.1046/j.1365-2222.00698.x
  • Fujimura M, Ohkura N, Abo M, et al. Exhaled nitric oxide levels in patients with atopic cough and cough variant asthma. Respirology. 2008;13(3):359–364. PMID: 18399857. doi:10.1111/j.1440-1843.2008.01273.x
  • Fujimura M, Abo M, Ogawa H, et al. Importance of atopic cough, cough variant asthma and sinobronchial syndrome as causes of chronic cough in the Hokuriku area of Japan. Respirology. 2005;10(2):201–207. PMID: 15823186. doi:10.1111/j.1440-1843.00686.x
  • Fujimura M, Nishi K, Ohka T, Yasui M, Kasahara K. Bronchial biopsy and sequential bronchoalveolar lavage in atopic cough: in view of the effect of histamine H1-receptor antagonists. Allergology Int. 2000;49(2):135–142. doi:10.1046/j.1440-1592.2000.00171.x
  • Fujimura M, Sakamoto S, Matsuda T. Bronchodilator-resistive cough in atopic patients: bronchial reversibility and hyperresponsiveness.. Intern Med. 1992;31(4):447–452. PMID: 1352997. doi:10.2169/internalmedicine.31
  • Niimi A, Amitani R, Suzuki K, Tanaka E, Murayama T, Kuze F. Eosinophilic inflammation in cough variant asthma. Eur Respir J. 1998;11(5):1064–1069. doi:10.1183/09031936.98.11051064
  • Corrao WM, Braman SS, Irwin RS. Chronic cough as the sole presenting manifestation of bronchial asthma. N Engl J Med. 1979;300(12):633–637. doi:10.1056/NEJM197903223001201
  • McGarvey LP, Birring SS, Morice AH, et al.; COUGH-1 and COUGH-2 Investigators. Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, Phase 3 trials. Lancet. 2022;399(10328):909–923. doi:10.1016/S0140-6736(21)02348-5
  • Ishiura Y, Fujimura M, Yamamoto H, Ishiguro T, Ohkura N, Myou S. COX-2 inhibition attenuates cough reflex sensitivity to inhaled capsaicin in patients with asthma. J Investig Allergol Clin Immunol. 2009;19(5):370–374. PMID: 19862936.
  • Ishiura Y, Fujimura M, Yamamoto H, et al. Effect of an orally active Th2 cytokine inhibitor, suplatast tosilate, on atopic cough. Arzneimittelforschung. 2008;58(6):297–302. PMID: 18677972. doi:10.1055/s-0031-1296510
  • Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MD, Pavord ID. Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax. 2003;58(4):339–343. doi:10.1136/thorax.58.4.339
  • Kamei J, Takahashi Y, Yoshikawa Y, Saitoh A. Involvement of P2X receptor subtypes in ATP-induced enhancement of the cough reflex sensitivity. Eur J Pharmacol. 2005;528(1–3):158–161. PMID: 16321375. doi:10.1016/j.ejphar.2005.10.030
  • Villalobos-Violan V, Betancor D, Mahíllo-Fernández I, Sastre J. Nonasthmatic eosinophilic bronchitis and asthma Analysis of Biomarkers. J Investig Allergol Clin Immunol. 2022;32(3):216–217. PMID: 34661536. doi:10.18176/jiaci.0738
  • Katz PO, Dunbar KB, Schnoll-Sussman FH, Greer KB, Yadlapati R, Spechler SJ. ACG clinical guideline: guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2022;117(1):27–56. PMID: 34807007. doi:10.14309/ajg.0000000000001538